Houston Cancer Institute is a clinical research site located in Houston, Texas, United States 77055.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Houston Cancer Institute has participated in 2 clinical trials.
Therapeutic areas: Multiple Myeloma, Adenocarcinoma of the Lung.
Sponsors: Millennium Pharmaceuticals, Inc., Morphotek.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Houston Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Houston Cancer Institute has 2 clinical trials on record. Their work covers Multiple Myeloma, Adenocarcinoma of the Lung.
Houston Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.